Chronic venous insufficiency (CVI) is a progressive and often underestimated condition affecting nearly 25% of the adult population. It can lead to discomfort, edema, varicosities, and ultimately venous ulcers if left untreated. Historically, thermal ablation techniques—radiofrequency (RFA) and endovenous laser ablation (EVLA)—have offered a solution, but not without trade-offs: thermal injury risk, tumescent anaesthesia, and extended downtime.
VenaBlock™ enters as a disruptive alternative. Leveraging a proprietary low-volume cyanoacrylate adhesive, this next-generation system allows for the permanent closure of incompetent veins in just minutes—without heat, incisions, or nerve injury risks. With VenaBlock™, varicose vein treatment enters the adhesive era—offering patients and clinicians a safer, faster, and more comfortable path to recovery.
KEY ADVANTAGES
Why are physicians and patients shifting to adhesive-based varicose vein therapies? Here’s what sets VenaBlock™ apart:
Non-thermal & non-tumescent
No risk of thermal damage, nerve injury, or complications from tumescent fluid infiltration.
Minimally invasive
With only a tiny access site, the procedure minimizes bruising, inflammation, and scarring.
Rapid intervention
The full treatment often takes less than 15 minutes per limb.
No compression garments needed
Unlike thermal methods, patients typically do not require compression stockings post-procedure.
Immediate ambulation
Most patients return to walking within an hour and resume normal life the same day.
Excellent cosmetic outcome
The absence of heat and large entry points reduces post-operative marks and pigmentation.
CLINICAL PROOF
In a multi-centre prospective study involving 342 patients, VenaBlock™ demonstrated:
- 97.8% anatomical closure at 12 months
- <2% retreatment rate
- High patient satisfaction across comfort, recovery, and cosmetic metrics
These outcomes underscore the reliability and long-term efficacy of adhesive-based venous closure—matching or exceeding those of conventional thermal procedures without the associated risks.
